Live Breaking News & Updates on Analyst Recommendations For Elevance Health|Page 5

Stay updated with breaking news from Analyst recommendations for elevance health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Elevance Health (NYSE:ELV) Given New $574.00 Price Target at Royal Bank of Canada

Elevance Health (NYSE:ELV – Free Report) had its target price upped by Royal Bank of Canada from $572.00 to $574.00 in a report published on Thursday, Benzinga reports. They currently have an outperform rating on the stock. ELV has been the subject of several other research reports. Cantor Fitzgerald reissued an overweight rating and issued […] ....

Cantor Fitzgerald , Morgan Stanley , Jpmorgan Chase Co , Geode Capital Management , Nuveen Asset Management , Elevance Health Stock , Sanders Capital , Analyst Recommendations For Elevance Health , News Ratings For Elevance Health Daily , Royal Bank , Elevance Health Inc , Elevance Health , Ltd Zurich , Bank Julius Baer Co , Free Report , Moderate Buy , Get Free Report , Julius Baer , Capital Management , Asset Management , Specialty Business , Government Business , Elevance Health Daily , Nyse Elv , Boost Price Target , Royal Bank Of Canada ,